Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Integrated Network Pharmacology Analysis and Experimental Validation to Elucidate the Mechanism of Acteoside in Treating Diabetic Kidney Disease

Zhang SJ, Zhang YF, Bai XH, Zhou MQ, Zhang ZY, Zhang SX, Cao ZJ, Wang L, Ding SW, Zheng HJ, Liu YN, Yu GY, Liu WJ

Drug Design, Development and Therapy 2024, 18:1439-1457

Published Date: 30 April 2024

Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure

Wang Z, Liu C, Wei J, Yuan H, Shi M, Zhang F, Zeng Q, Huang A, Du L, Li Y, Guo Z

Drug Design, Development and Therapy 2024, 18:1415-1438

Published Date: 30 April 2024

The Molecular Biological Mechanism of Hydrogen Therapy and Its Application in Spinal Cord Injury

Hu Q, Li Y, Lin Z, Zhang H, Chen H, Chao C, Zhao C

Drug Design, Development and Therapy 2024, 18:1399-1414

Published Date: 29 April 2024

Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm

Zhang J, Wu L, Wang C, Xie X, Han Y

Drug Design, Development and Therapy 2024, 18:1385-1398

Published Date: 26 April 2024


Read more articles